The government will work hand-in-hand with the medical fraternity to communicate innovative ideas to the general public to help reduce diabetes cases in the country, said
Union minister of state for power and coal Piyush Goyal.
Two-day Diabetes Summit revolved around new drugs, mechanisms and complications involved in treating with them. Pros and cons of using the newest entrant in the diabetes care area the sodium-glucose co-transporter 2 (SGLT2) inhibitors were discussed in the summit.
Piyush Goyal emphasized that it is important for doctors to understand the latest trends in treatment across the world. "We feel a little more reassured that we are all in safe hands. They land up with chronic diseases like diabetes because of an uncontrolled lifestyle," said the minister who is known to lead a fit and healthy lifestyle. Physician Dr Hemant Thacker said that the summit was aimed at translating podium-projected presentations to bedside tips, which will benefit consultants, patients and the community at large.
"It is showing great results but it is not for each and every patient. It is mainly for those grappling with weight issues but contraindicated for patients with recurrent genital or urinary infections," said Nagpur-based diabetologist Dr Pramod Gandhi. He also added that it cannot be used in pre-diabetics.